Literature DB >> 21462611

Renal replacement therapies.

Gautam Phadke1, Ramesh Khanna.   

Abstract

The kidneys perform a wide array of functions in the body, most of which are essential for life. Regulation of water and electrolytes, excretion of metabolic waste and of bioactive substances like hormones, drugs etc., which affect bodily functions; regulation of arterial blood pressure, red blood cell and vitamin D production; are some of the major functions that the kidneys perform. It is obvious then, that patients with renal failure present a steep challenge to the physician taking care of this special population. Renal replacement therapy remains only a part of treatment that helps substitute the regulation of water and electrolytes, removal of metabolic waste, and to a certain extent removal of drugs and other bioactive substances from the body. This article aims to provide an understanding of different types of renal replacement therapy, mainly to patients with end-stage renal disease (ESRD).

Entities:  

Mesh:

Year:  2011        PMID: 21462611      PMCID: PMC6188448     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  18 in total

Review 1.  Review on uremic toxins: classification, concentration, and interindividual variability.

Authors:  Raymond Vanholder; Rita De Smet; Griet Glorieux; Angel Argilés; Ulrich Baurmeister; Philippe Brunet; William Clark; Gerald Cohen; Peter Paul De Deyn; Reinhold Deppisch; Beatrice Descamps-Latscha; Thomas Henle; Achim Jörres; Horst Dieter Lemke; Ziad A Massy; Jutta Passlick-Deetjen; Mariano Rodriguez; Bernd Stegmayr; Peter Stenvinkel; Ciro Tetta; Christoph Wanner; Walter Zidek
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

Review 2.  Dialysis without membranes: how and why?

Authors:  Edward F Leonard; Alan C West; Nina C Shapley; Mona U Larsen
Journal:  Blood Purif       Date:  2004       Impact factor: 2.614

Review 3.  Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study.

Authors:  E Lars Penne; Peter J Blankestijn; Michiel L Bots; Marinus A van den Dorpel; Muriel P C Grooteman; Menso J Nubé; Piet M ter Wee
Journal:  Semin Dial       Date:  2005 Jan-Feb       Impact factor: 3.455

4.  Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application?

Authors:  Richard A Ward
Journal:  J Am Soc Nephrol       Date:  2005-06-23       Impact factor: 10.121

Review 5.  Epidemiology of peritoneal dialysis: a story of believers and nonbelievers.

Authors:  Norbert Lameire; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2009-12-15       Impact factor: 28.314

6.  Last chance to stop and think on risks of xenotransplants.

Authors:  D Butler
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

7.  Prediction of early death in end-stage renal disease patients starting dialysis.

Authors:  B J Barrett; P S Parfrey; J Morgan; P Barré; A Fine; M B Goldstein; S P Handa; K K Jindal; C M Kjellstrand; A Levin; H Mandin; N Muirhead; R M Richardson
Journal:  Am J Kidney Dis       Date:  1997-02       Impact factor: 8.860

8.  The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.

Authors:  Edward F Vonesh; Jon J Snyder; Robert N Foley; Allan J Collins
Journal:  Kidney Int       Date:  2004-12       Impact factor: 10.612

9.  Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity.

Authors:  S M Chandna; J Schulz; C Lawrence; R N Greenwood; K Farrington
Journal:  BMJ       Date:  1999-01-23

Review 10.  The wearable artificial kidney, why and how: from holy grail to reality.

Authors:  Victor Gura; Claudio Ronco; Andrew Davenport
Journal:  Semin Dial       Date:  2008-10-16       Impact factor: 3.455

View more
  1 in total

1.  An Iranian experience on renal allograft diseases.

Authors:  Diana Taheri; Ardeshir Talebi; Venus Salem; Mehdi Fesharakizadeh; Shahaboddin Dolatkhah; Parvin Mahzouni
Journal:  J Res Med Sci       Date:  2011-12       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.